Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jose R. Murillo"'
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(1)
Introduction The safety and efficacy of direct oral anticoagulants in cancer patients is currently unclear. Low-molecular-weight heparin remains the standard of care for cancer patients with venous thromboembolism, with warfarin, a vitamin K antagoni
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 34:686-694
tudy Objective To evaluate the impact of a pharmacy protocol that converts standard rituximab infusions to a rapid 90-minute infusion on the duration of outpatient infusion center clinic visits. Design Prospective interventional study. Setting Outpat
Publikováno v:
Community Oncology. 7:458-461
The aim of this study was to determine whether noninitial rituximab doses can be safely administered by a rapid, 90-minute infusion for patients with a CD20-positive B-cell malignancy with or without steroid-containing chemotherapy regimens. Thirteen
Publikováno v:
Journal of Pharmacy Practice. 21:138-145
Peripheral nervous system (PNS) toxicity is a common and potentially serious adverse effect of several different systemic chemotherapeutic agents. The central nervous system (CNS) is protected from exposure to toxic agents by the tight junctions of e
Publikováno v:
Pharmacotherapy. 24:526-531
Serotonin (5-hydroxytryptamine [5-HT])1 receptor agonists, such as those used for treating migraine, can cause coronary artery contraction, coronary spasm, and even myocardial infarction. Tegaserod maleate is a relatively new 5-HT4 receptor agonist w
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 17(4)
Background. The World Health Organization classifies myelodysplastic syndromes (MDS) as a group of hematologic malignancies where at least one myeloid lineage contains ≥10% cells with myelodysplasia. Therapy-related MDS (t-MDS) may result from trea
Autor:
Jose R. Murillo, Jim M. Koeller
Publikováno v:
The oncologist. 11(10)
Purpose. To characterize the chemotherapy given near the end of life to advanced non-small cell lung cancer (NSCLC) patients treated in the community oncology setting using a medical records database. Methods. We conducted a retrospective chart revie